Genomic Health (GHDX) Tops Q3 EPS by 1c

November 1, 2016 4:42 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Genomic Health (NASDAQ: GHDX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $82.3 million versus the consensus estimate of $83.24 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment